Cargando…

Rituximab and Abatacept Are Effective in Differential Treatment of Interstitial Lymphocytic Lung Disease in Children With Primary Immunodeficiencies

BACKGROUND: Interstitial lymphocytic lung disease (ILLD), a recently recognized complication of primary immunodeficiencies (PID), is caused by immune dysregulation, abnormal bronchus-associated lymphoid tissue (BALT) hyperplasia, with subsequent progressive loss of pulmonary function. Various modes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rodina, Yulia, Deripapa, E., Shvets, O., Mukhina, A., Roppelt, A., Yuhacheva, D., Laberko, A., Burlakov, V., Abramov, D., Tereshchenko, G., Novichkova, G., Shcherbina, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458825/ https://www.ncbi.nlm.nih.gov/pubmed/34566961 http://dx.doi.org/10.3389/fimmu.2021.704261

Ejemplares similares

Differential diagnosis of CRMO
por: Kozlova, A, et al.
Publicado: (2015)

Hematopoietic stem cell transplantation in a patient with type 1 mosaic variegated aneuploidy syndrome
por: Laberko, Alexandra, et al.
Publicado: (2019)

Complex Multisystem Phenotype With Immunodeficiency Associated With NBAS Mutations: Reports of Three Patients and Review of the Literature
por: Khoreva, Anna, et al.
Publicado: (2020)

Prospective Study of a Cohort of Russian Nijmegen Breakage Syndrome Patients Demonstrating Predictive Value of Low Kappa-Deleting Recombination Excision Circle (KREC) Numbers and Beneficial Effect of Hematopoietic Stem Cell Transplantation (HSCT)
por: Deripapa, Elena, et al.
Publicado: (2017)

Novel hemizygous CORO1A variant leads to combined immunodeficiency with defective platelet calcium signaling and cell mobility
por: Khoreva, Anna, et al.
Publicado: (2023)

Incidence and complications of interstitial lung disease in users of tocilizumab, rituximab, abatacept and anti-tumor necrosis factor α agents, a retrospective cohort study
por: Curtis, Jeffrey R., et al.
Publicado: (2015)

Rituximab and abatacept but not tocilizumab impair antibody response to pneumococcal conjugate vaccine in patients with rheumatoid arthritis
por: Crnkic Kapetanovic, Meliha, et al.
Publicado: (2013)

Cost-effectiveness of abatacept, tocilizumab and TNF-inhibitors compared with rituximab as second-line biologic drug in rheumatoid arthritis
por: Huoponen, Saara, et al.
Publicado: (2019)

Rituximab: Humoral immunodeficiency: case report
Publicado: (2021)

Abatacept in rheumatoid arthritis-associated interstitial lung disease: short-term outcomes and predictors of progression
por: Tardella, Marika, et al.
Publicado: (2021)

A retrospective study of the efficacy of JAK inhibitors or abatacept on rheumatoid arthritis-interstitial lung disease
por: Tardella, Marika, et al.
Publicado: (2022)

Free-breathing T2* mapping for MR myocardial iron assessment at 3 T
por: Nazarova, E. E., et al.
Publicado: (2020)

Interstitial lung disease in patients with scleroderma - Treatment with rituximab
por: Muñoz, A, et al.
Publicado: (2010)

Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort study
por: Gottenberg, Jacques-Eric, et al.
Publicado: (2019)

Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study
por: Cassone, Giulia, et al.
Publicado: (2020)

Safety and Effectiveness of Abatacept in a Prospective Cohort of Patients with Rheumatoid Arthritis–Associated Interstitial Lung Disease
por: Mena-Vázquez, Natalia, et al.
Publicado: (2022)

PReS-FINAL-2327: Abatacept in the treatment of refractory uveitis
por: Moretti, D, et al.
Publicado: (2013)

Immunosuppressive therapy with rituximab in common variable immunodeficiency
por: Pecoraro, Antonio, et al.
Publicado: (2019)

Case Report: “Primary Immunodeficiency”—Severe Autoimmune Enteropathy in a Pediatric Heart Transplant Recipient Treated With Abatacept and Alemtuzumab
por: Kalaidina, Elizaveta, et al.
Publicado: (2022)

Subcutaneous Abatacept vErsus Intravenous Abatacept: A Phase IIIb Noninferiority Study in Patients With an Inadequate Response to Methotrexate
por: Genovese, M C, et al.
Publicado: (2011)

Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials
por: Salliot, C, et al.
Publicado: (2009)

Rituximab treatment in patients with systemic sclerosis and interstitial lung disease
por: Mohammed, Abdel Gaffar A., et al.
Publicado: (2017)

Rituximab for interstitial pneumonia with autoimmune features at two medical centres
por: D’Silva, Kristin M, et al.
Publicado: (2021)

Serious Hemorrhagic Complications After Successful Treatment of Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy With Defibrotide in Pediatric Patient With Myelodysplastic Syndrome
por: Laberko, Alexandra, et al.
Publicado: (2020)

Abatacept in the treatment of rheumatoid arthritis
por: Buch, Maya H, et al.
Publicado: (2008)

Abatacept in the treatment of rheumatoid arthritis
por: Vital, Edward M, et al.
Publicado: (2006)

Abatacept treatment for rheumatoid arthritis
por: Schiff, Michael
Publicado: (2011)

PReS-FINAL-2198: Insufficient efficacy of tocilizumab therapy in children with Castleman's disease
por: Kozlova, A, et al.
Publicado: (2013)

Second allogeneic hematopoietic stem cell transplantation in patients with inborn errors of immunity
por: Laberko, Alexandra, et al.
Publicado: (2022)

Two Cases of Interstitial Pneumonitis Caused by Rituximab Therapy
por: Lee, Yuna, et al.
Publicado: (2006)

Rituximab-associated interstitial lung disease in fibrillary glomerulonephritis
por: Sainz-Prestel, Valeria, et al.
Publicado: (2013)

Interstitial pneumonitis related to rituximab therapy for Waldenström's macroglobulinemia
por: Bai, Xueyan, et al.
Publicado: (2015)

PReS-FINAL-2245: A rare case of subcutaneous panniculitis-like T cell lymphoma in a 9-month-old child
por: Kozlova, A, et al.
Publicado: (2013)

Abatacept: the evidence for its place in the treatment of rheumatoid arthritis
por: Köller, Marcus D.
Publicado: (2007)

Rituximab-induced interstitial lung disease: five case reports
por: Naqibullah, Matiuallah, et al.
Publicado: (2015)

A rare case of rituximab induced interstitial lung disease
por: Sahu, Kamal Kant, et al.
Publicado: (2016)

Subcutaneous abatacept for the treatment of rheumatoid arthritis
por: Schiff, Michael
Publicado: (2013)

Experience with abatacept in refractory lupus nephritis
por: Calatayud, Emma, et al.
Publicado: (2023)

Lymphocytic Interstitial Pneumonia in a Man with Human Immunodeficiency Virus Infection
por: Tasdemir, Merve Nur, et al.
Publicado: (2023)

Primary Immunodeficiencies in Russia: Data From the National Registry
por: Mukhina, Anna A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_f9jlv7695b8vcdf9btrc3kjav8